Generic Name: ibalizumab-uiyk
Brand Names: Trogarzo
Medically reviewed by Drugs.com. Last updated on Jun 12, 2018.
What is Trogarzo?
Trogarzo is used to treat HIV, the virus that can cause acquired immunodeficiency syndrome (AIDS). Ibalizumab-uiyk is not a cure for HIV or AIDS.
Trogarzo is usually given after other treatments have failed.
Before taking this medicine
You should not use Trogarzo if you are allergic to ibalizumab.
Before you receive Trogarzo, tell your doctor about all your medical conditions or allergies.
Tell your doctor if you are pregnant, and use your medications properly to control your infection. HIV can be passed to your baby if the virus is not controlled during pregnancy. Your name may be listed on a registry to track any effects of antiviral medicine on the baby.
Women with HIV or AIDS should not breast feed a baby. Even if your baby is born without HIV, the virus may be passed to the baby in your breast milk.
How is Trogarzo given?
Trogarzo is given as an infusion into a vein. A healthcare provider will give you this injection, usually once every 2 weeks.
The infusion can take at least 15 minutes to complete.
HIV is often treated with a combination of drugs. Use all medications as directed and read all medication guides you receive. Do not change your dose or dosing schedule without your doctor's advice. Every person with HIV should remain under the care of a doctor.
Trogarzo dosing information
Usual Adult Dose for HIV Infection:
Loading dose: 2000 mg IV once
Maintenance dose: 800 mg IV every 2 weeks
Use: In combination with other antiretroviral(s), for the treatment of HIV-1 infection in heavily therapy-experienced patients with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen
What happens if I miss a dose?
Call your doctor for instructions if you miss an appointment for your Trogarzo injection.
What happens if I overdose?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
What should I avoid while receiving Trogarzo?
Using this medicine will not prevent you from passing HIV to other people. Do not have unprotected sex or share razors or toothbrushes. Talk with your doctor about safe ways to prevent HIV transmission during sex. Sharing drug or medicine needles is never safe, even for a healthy person.
Trogarzo side effects
Get emergency medical help if you have signs of an allergic reaction to Trogarzo: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Ibalizumab affects your immune system, which may cause certain side effects (even weeks or months after you've taken this medicine). Tell your doctor if you have:
signs of a new infection - fever, night sweats, swollen glands, cold sores, cough, wheezing, diarrhea, weight loss;
trouble speaking or swallowing, problems with balance or eye movement, weakness or prickly feeling; or
swelling in your neck or throat (enlarged thyroid), menstrual changes, impotence.
Common Trogarzo side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What other drugs will affect Trogarzo?
Other drugs may interact with ibalizumab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Trogarzo only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2019 Cerner Multum, Inc. Version: 1.01.
- How is Trogarzo used in the treatment of HIV?
- What are the side effects with HIV treatment Trogarzo?
- How well does Trogarzo work to treat multidrug-resistant (MDR) HIV-1?
More about Trogarzo (ibalizumab)
- Side Effects
- During Pregnancy
- Dosage Information
- Pricing & Coupons
- En Español
- Drug class: miscellaneous antivirals
- FDA Approval History